Undetectable prostate-specific antigen response with bicalutamide withdrawal phenomenon.

Authors

• E A El-Gabry
• S E Strup
• L G Gomella

Publication/Presentation Date

9-1-2000

Abstract

Several reports have described the antiandrogen withdrawal syndrome with various nonsteroidal antiandrogen agents. To our knowledge, there have been no reports describing a durable undetectable prostate-specific antigen (PSA) response with discontinuation of the antiandrogen agent bicalutamide (Casodex, Zeneca, Wilmington, DE, U.S.A.). We report a case in which a decline of serum PSA to undetectable levels was achieved with bicalutamide discontinuation.

Volume

6

Issue

3

First Page

221

Last Page

222

ISSN

1079-3259

Published In/Presented At

El-Gabry, E. A., Strup, S. E., & Gomella, L. G. (2000). Undetectable prostate-specific antigen response with bicalutamide withdrawal phenomenon. Techniques in urology, 6(3), 221–222.

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

10963494

Department(s)

Administration and Leadership

Document Type

Article